PPMI Presentations at MDS 2014 Stockholm

PPMI will be well-represented at the International Parkinson and Movement Disorders Society’s upcoming 18th annual congress happening June 8-12 in Stockholm, Sweden.  We invite attendees to view the following posters and presentations:

Monday 6/9/2014

2102: Plenary Session: Time: 10:30 ? 12:30

10:30 What do we now know about synuclein?s role in Parkinson?s disease pathology? – John Trojanowski
Topic: New insights into the pathology, progression and heterogeneity of Parkinson?s disease
Location: Room A1

Poster Viewing: 9:00 ? 18:00 (6:00pm)/ Poster session 12:30 ? 14:00 (2:00pm)
Location: Exhibition Hall B

246: Multicenter evaluation of Parkinson?s disease progression using 123-I I-Ioflupane SPECT: Update from the Parkinson?s progression marker initiative trial
Topic: Neuroimaging

262: Degeneration of corticostriatal fibers in Parkinson?s disease and their differential relations to cognitive motor deficits
Topic: Neuroimaging

Poster Tour: 12:30 ? 14:00 (2:00pm)

729: The Parkinson?s progression marker initiative (PPMI) ? Assessment of clinical, imaging and CSF PD biomarkers
Topic: Parkinson?s disease: Clinical trials
Location: Room A9

Tuesday 6/10/2014

Poster Viewing: 9:00 ? 18:00 (6:00pm)/ Poster session 12:30 ? 14:00 (2:00pm)
Location: Exhibition Hall B

729: The Parkinson?s progression marker initiative (PPMI) ? Assessment of clinical, imaging and CSF PD biomarkers
Topic: Parkinson?s disease: Clinical trials

Poster Tour: 12:30 ? 14:00 (2:00pm)

903: Cognitive performance and psychiatric symptoms in de novo, untreated Parkinson?s disease: Results from the PPMI study
Topic: Parkinson?s disease: Behavioral disorders
Location: Room A8

Wednesday 6/11/2014

Poster Viewing: 9:00 ? 18:00 (6:00pm)/ Poster session 12:00 ? 13:30 (1:30pm)
Location: Exhibition Hall B

803: Excessive day time sleepiness is not part of Parkinson?s disease disability in de novo patients: Results from the PPMI study
Topic: Parkinson?s disease: Sleep disorders

903: Cognitive performance and psychiatric symptoms in de novo, untreated Parkinson?s disease: Results from the PPMI study
Topic: Parkinson?s disease: Behavioral disorders

1064: Can we reliably establish Parkinson?s disease subtypes in de novo patients: Results from the PPMI study
Topic: Parkinson?s disease: Phenomenology

Thursday 6/12/2014

5103 Blue Ribbon Highlights 11:00 – 12:00pm

1064: Can we reliably establish Parkinson?s disease subtypes in de novo patients: Results from the PPMI study
Location: Room A1

5310: Teaching Course: 15:00 – 17:00

15:40  How to assess patients in clinical trials with experimental therapies for Parkinson?s disease K. Marek
Topic: Biochemical and Imaging Markers
Location: Room A7